TIMI PERFUSION GRADE-3 BUT NOT GRADE-2 RESULTS IN IMPROVED OUTCOME AFTER THROMBOLYSIS FOR MYOCARDIAL-INFARCTION - VENTRICULOGRAPHIC, ENZYMATIC, AND ELECTROCARDIOGRAPHIC EVIDENCE FROM THE TEAM-3 STUDY

被引:265
作者
ANDERSON, JL [1 ]
KARAGOUNIS, LA [1 ]
BECKER, LC [1 ]
SORENSEN, SG [1 ]
MENLOVE, RL [1 ]
机构
[1] JOHNS HOPKINS UNIV, BALTIMORE, MD 21218 USA
关键词
CLINICAL TRIALS; REPERFUSION; MYOCARDIAL INFARCTION;
D O I
10.1161/01.CIR.87.6.1829
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Coronary patency has been used as a measure of thrombolysis success after acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Study Group perfusion grades have gained wide acceptance, with grades 0 (no distal flow) and 1 perfusion (minimal flow) being designated as thrombolysis failures and grades 2 (partial perfusion) and 3 (complete perfusion) as thrombolysis successes. However, the significance of the individual TIMI grades on clinical outcome has not been adequately assessed. Methods and Results. To evaluate the functional significance of TIMI perfusion grades, we compared 1-day coronary patency status with ventriculographic, enzymatic, and ECG indexes of acute myocardial infarction in 298 patients treated with anistreplase or alteplase within 4 hours of myocardial infarction symptom onset. Radionuclide ejection fraction was determined at 1 week and at 1 month. Perfusion grades for the entire study population were distributed as 12% (n = 37) grades 0/1, 13% (n = 40) grade 2, and 74% (n=221) grade 3. Patency profile did not differ between the two thrombolytic regimens. Further coronary interventions were performed after the 1-day patency determination in 43% of patients (43%, 48%, 42%, respectively, in grades 0/1, 2, and 3 patients). The outcome of grade 2 patients did not differ from grades 0/1 patients in ejection fraction, enzyme peaks, ECG markers, or morbidity index. In contrast, grade 3 patients, compared with grades 0-2 patients, showed 1) a greater global ejection fraction at 1 week (54% versus 49%, p = 0.006) and at 1 month (54% versus 49%, p = 0.01), 2) a greater infarct zone ejection fraction at 1 week (41% versus 33%, p=0.003) and at 1 month (42% versus 32%, p=0.003), 3) smaller enzyme peaks, significant for lactate dehydrogenase, and shorter times to enzyme peaks, significant for all four enzymes, 4) a smaller QRS score at discharge and at 1 month, and 5) a trend toward a lower morbidity index. Conclusions. Grade 3 flow predicts significantly better outcomes than lesser grades of flow and represents an important measure of reperfusion success.
引用
收藏
页码:1829 / 1839
页数:11
相关论文
共 49 条
  • [1] ANISTREPLASE VERSUS ALTEPLASE IN ACUTE MYOCARDIAL-INFARCTION - COMPARATIVE EFFECTS OF LEFT-VENTRICULAR FUNCTION, MORBIDITY AND 1-DAY CORONARY-ARTERY PATENCY
    ANDERSON, JL
    BECKER, LC
    SORENSEN, SG
    KARAGOUNIS, LA
    BROWNE, KF
    SHAH, PK
    MORRIS, DC
    FINTEL, DJ
    MUELLER, HS
    ROSS, AM
    HALL, SM
    ASKINS, JC
    DOOREY, AJ
    GRINES, CL
    MORENO, FL
    MARDER, VJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (04) : 753 - 766
  • [2] MULTICENTER REPERFUSION TRIAL OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC) IN ACUTE MYOCARDIAL-INFARCTION - CONTROLLED COMPARISON WITH INTRACORONARY STREPTOKINASE
    ANDERSON, JL
    ROTHBARD, RL
    HACKWORTHY, RA
    SORENSEN, SG
    FITZPATRICK, PG
    DAHL, CF
    HAGAN, AD
    BROWNE, KF
    SYMKOVIAK, GP
    MENLOVE, RL
    BARRY, WH
    ECKERSON, HW
    MARDER, VJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (06) : 1153 - 1163
  • [3] THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - MAKING SENSE OF THE CLINICAL-TRIALS DATA
    ANDERSON, JL
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 1992, 5 (02) : 127 - 136
  • [4] ANDERSON JL, 1984, CIRCULATION, V70, P606, DOI 10.1161/01.CIR.70.4.606
  • [5] A RANDOMIZED TRIAL OF INTRACORONARY STREPTOKINASE IN THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION
    ANDERSON, JL
    MARSHALL, HW
    BRAY, BE
    LUTZ, JR
    FREDERICK, PR
    YANOWITZ, FG
    DATZ, FL
    KLAUSNER, SC
    HAGAN, AD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (22) : 1312 - 1318
  • [6] MULTICENTER PATENCY TRIAL OF INTRAVENOUS ANISTREPLASE COMPARED WITH STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION
    ANDERSON, JL
    SORENSEN, SG
    MORENO, FL
    HACKWORTHY, RA
    BROWNE, KF
    DALE, HT
    LEYA, F
    DANGOISSE, V
    ECKERSON, HW
    MARDER, VJ
    [J]. CIRCULATION, 1991, 83 (01) : 126 - 140
  • [7] ANDERSON JL, 1991, AM J CARDIOL, V68, pE11
  • [8] [Anonymous], 1988, LANCET, V2, P349
  • [9] [Anonymous], 1986, Lancet, V1, P397
  • [10] USEFULNESS OF RECANALIZATION TO LUMINAL DIAMETER OF 0.6 MILLIMETER OR MORE WITH INTRACORONARY STREPTOKINASE DURING ACUTE MYOCARDIAL-INFARCTION IN PREDICTING NORMAL PERFUSION STATUS, CONTINUED ARTERIAL PATENCY AND SURVIVAL AT ONE YEAR
    BADGER, RS
    BROWN, BG
    KENNEDY, JW
    MATHEY, D
    GALLERY, CA
    BOLSON, EL
    DODGE, HT
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (06) : 519 - 522